Effectiveness and feasibility of external beam radiotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium involvement: a multicenter trial in Korea (KROG 17-10)

References

• Abou-Alfa GK, Meyer T, Cheng A-L, El-Khoueiry AB, Rimassa L, Ryoo B-Y, Cicin I, Merle P, Park J-W, Blanc J-F. 2018. Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase III CELESTIAL trial. San Francisco (CA): American Society of Clinical Oncology.
   Google Scholar
• Bruix J, Qin S, Merle P, Granito A, Huang Y-H, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V. 2017. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 389(10064):56–66.
   PubMed Web of Science ®Google Scholar
• Chern MC, Chuang VP, Cheng T, Lin ZH, Lin YM. 2008. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with inferior vena cava and right atrial tumors. Cardiovasc Intervent Radiol. 31(4):735–744.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. 1995. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 31(5):1341–1346.
   PubMed Web of Science ®Google Scholar
• Eisenhauer E.A, Therasse P, Bogaerts J, Schwartz L.H, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. 2009. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 45(2):228–247.
   PubMed Web of Science ®Google Scholar
• Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. 2005. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 242(4):540.
   PubMed Web of Science ®Google Scholar
• Holliday EB, Allen PK, Elhalawani H, Abdel-Rahman O. 2018. Treatment at a high‐volume centre is associated with improved survival among patients with non‐metastatic hepatocellular carcinoma. Liver Int. 38(4):665–675.
   PubMed Web of Science ®Google Scholar
• Hou JZ, Zeng ZC, Zhang JY, Fan J, Zhou J, Zeng MS. 2012. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys. 84(2):362–368.
   PubMed Web of Science ®Google Scholar
• Igaki H, Nakagawa K, Shiraishi K, Shiina S, Kokudo N, Terahara A, Yamashita H, Sasano N, Omata M, Ohtomo K. 2008. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion. Jpn J Clin Oncol. 38(6):438–444.
   PubMed Web of Science ®Google Scholar
• Koay EJ, Owen D, Das P. 2018. Radiation-induced liver disease and modern radiotherapy. Semin Radiat oncol. 28(4):321–331.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Niwa Y, Mima M, Fujii O, Sasaki R, Yamada I, et al. 2011. The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J Gastroenterol. 46(7):913–920.
   PubMed Web of Science ®Google Scholar
• Koo JE, Kim JH, Lim YS, Park SJ, Won HJ, Sung KB, Suh DJ. 2010. Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 78(1):180–187.
   PubMed Web of Science ®Google Scholar
• Korean Liver Cancer Study, National Cancer Center. 2018. Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinom. http://livercancer.or.kr/study/guidelines.php.
   Google Scholar
• Kouloulias V, Mosa E, Georgakopoulos J, Platoni K, Brountzos I, Zygogianni A, Antypas C, Kosmidis P, Mystakidou K, Tolia M, et al. 2013. Three-dimensional conformal radiotherapy for hepatocellular carcinoma in patients unfit for resection, ablation, or chemotherapy: a retrospective study. ScientificWorldJournal. 2013:780141
   PubMedGoogle Scholar
• Lee IJ, Chung JW, Kim HC, Yin YH, So YH, Jeon UB, Jae HJ, Cho BH, Park JH. 2009. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. J Vasc Interv Radiol. 20(1):22–29.
   PubMed Web of Science ®Google Scholar
• Llovet J M, Bustamante J, Castells A, Vilana R, Ayuso M D C, Sala M, Brú C, Rodés J, Bruix J. 1999. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 29(1):62–67.
   PubMed Web of Science ®Google Scholar
• Ma WJ, Wang HY, Teng LS. 2013. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Onc. 11(1):212.
   PubMedGoogle Scholar
• Mun Y-O, Park E-C, Sin H-R, Won Y-J, Jeong G-W, Hwang S-Y, Lee J-H, Gong H-J, Hwang S-S, Lee J-G. 2006. 우리나라 암환자의 의료기관 접근성의 지역간 불균형. Epidemiol Health. 28(2):152–161.
   Google Scholar
• Munoz-Schuffenegger P, Ng S, Dawson LA. 2017. Radiation-induced liver toxicity. Semin Radiat Oncol. 27(4):350–357.
   PubMed Web of Science ®Google Scholar
• Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. 1984. The natural history of hepatocellular carcinoma. a study of 100 untreated cases. Cancer. 54(7):1461–1465.
   PubMed Web of Science ®Google Scholar
• Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK. 2010. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 76(3):S94–S100.
   PubMed Web of Science ®Google Scholar
• Rim CH, Kim CY, Yang DS, Yoon WS. 2018a. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review. Radiother Oncol. 129(1):112–122.
   PubMed Web of Science ®Google Scholar
• Rim CH, Kim CY, Yang DS, Yoon WS. 2018b. External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: a meta-analysis and systemic review. Radiother Oncol. 129(1):123–129.
   PubMed Web of Science ®Google Scholar
• Rim CH, Yoon WS. 2018. Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials. Onco Targets Ther. 11:2865–2874.
   PubMed Web of Science ®Google Scholar
• Wakayama K, Kamiyama T, Yokoo H, Kakisaka T, Kamachi H, Tsuruga Y, Nakanishi K, Shimamura T, Todo S, Taketomi A. 2013. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Onc. 11(1):259.
   PubMedGoogle Scholar
• Xi M, Zhang L, Zhao L, Li QQ, Guo SP, Feng ZZ, Deng XW, Huang XY, Liu MZ. 2013. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS One. 8(5):e63864.
   PubMed Web of Science ®Google Scholar
• Yang SL, Liu LP, Yang S, Liu L, Ren JW, Fang X, Chen G. Lai PB. 2016. Preoperative serum α‐fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg. 103(6):716–724.
   PubMed Web of Science ®Google Scholar
• Yu SJ. 2016. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol. 22(1):7–17.
   PubMed Web of Science ®Google Scholar
• Zhang T, Huang JW, Zeng Y. 2013. [Surgery for patients with hepatocellular carcinoma and inferior vena cava tumor thrombus]. Sichuan Da Xue Xue Bao Yi Xue Ban. 44(6):1005–1008.
   PubMedGoogle Scholar